RxSight, Inc. (RXST) on GreekSoup https://greeksoup.ai/stocks/us/rxst/ Every dated entry in the public record on RxSight, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 RxSight, Inc.: Schedule 13G/A filed by BlackRock Portfolio Management LLC, 8.4% of the classhttps://greeksoup.ai/stocks/us/rxst/holders/us:RXST:schedule-13:2026-10-27:8299b1d26cTue, 27 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Schedule 13G/A filed by BlackRock, Inc., 6.9% of the classhttps://greeksoup.ai/stocks/us/rxst/holders/us:RXST:schedule-13:2026-10-27:2a3e41113cTue, 27 Oct 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> RxSight, Inc.: short interest 4,118,769 shares at the 15 October 2026 settlement, 6.10 days to coverhttps://greeksoup.ai/stocks/us/rxst/short-interest/us:RXST:short-interest:2026-10-15:742e3e387fThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> RxSight, Inc.: short interest 4,087,921 shares at the 30 September 2026 settlement, 4.63 days to coverhttps://greeksoup.ai/stocks/us/rxst/short-interest/us:RXST:short-interest:2026-09-30:26338b19d2Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> RxSight, Inc.: short interest 3,975,689 shares at the 15 September 2026 settlement, 5.52 days to coverhttps://greeksoup.ai/stocks/us/rxst/short-interest/us:RXST:short-interest:2026-09-15:ff222f970dTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Form 144, Goldshleger Ilya plans to sell 2,041 shares worth $14,205 around 2 September 2026https://greeksoup.ai/stocks/us/rxst/planned-sales/us:RXST:planned-sale:2026-09-02:1c18e17ba9Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Form 144, Weinberg Eric plans to sell 2,041 shares worth $14,205 around 2 September 2026https://greeksoup.ai/stocks/us/rxst/planned-sales/us:RXST:planned-sale:2026-09-02:7c34b19f06Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Form 144, Kurtz Ronald M MD plans to sell 5,100 shares worth $35,496 around 2 September 2026https://greeksoup.ai/stocks/us/rxst/planned-sales/us:RXST:planned-sale:2026-09-02:3b69bb60e6Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Form 144, Wilterding Mark plans to sell 7,765 shares worth $54,044 around 2 September 2026https://greeksoup.ai/stocks/us/rxst/planned-sales/us:RXST:planned-sale:2026-09-02:ffa76db8b7Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Kurtz Ronald M Md (Chief Medical Officer) sold 5,100 shares at $6.96 on 2 September 2026, $35,496https://greeksoup.ai/stocks/us/rxst/insiders/us:RXST:insider:2026-09-02:cf6565ee27Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Wilterding Mark (Chief Financial Officer) sold 7,765 shares at $6.96 on 2 September 2026, $54,044https://greeksoup.ai/stocks/us/rxst/insiders/us:RXST:insider:2026-09-02:fbff993d23Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Goldshleger Ilya (Chief Operating Officer) sold 2,041 shares at $6.96 on 2 September 2026, $14,205https://greeksoup.ai/stocks/us/rxst/insiders/us:RXST:insider:2026-09-02:05d1433c6bWed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Weinberg Eric (See remarks) sold 2,041 shares at $6.96 on 2 September 2026, $14,205https://greeksoup.ai/stocks/us/rxst/insiders/us:RXST:insider:2026-09-02:3166a177fcWed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> RxSight, Inc.: short interest 3,875,674 shares at the 31 August 2026 settlement, 4.63 days to coverhttps://greeksoup.ai/stocks/us/rxst/short-interest/us:RXST:short-interest:2026-08-31:cca51dd6d6Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Schedule 13G filed by Point72 Asset Management, L.P., 6.0% of the classhttps://greeksoup.ai/stocks/us/rxst/holders/us:RXST:schedule-13:2026-08-19:24e60dcca3Wed, 19 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Form 144, RAYMOND W COHEN plans to sell 11,890 shares worth $75,749 around 18 August 2026https://greeksoup.ai/stocks/us/rxst/planned-sales/us:RXST:planned-sale:2026-08-18:9500bd5b4eTue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> RxSight, Inc.: short interest 4,260,075 shares at the 14 August 2026 settlement, 4.52 days to coverhttps://greeksoup.ai/stocks/us/rxst/short-interest/us:RXST:short-interest:2026-08-14:3090611057Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> RxSight, Inc. Q2 FY2026 results: revenue $27 million, net income -$12 millionhttps://greeksoup.ai/stocks/us/rxst/results/fy2026-q2/us:RXST:result:2026-08-05:813f3bbfdeWed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> RxSight, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/rxst/filings/us:RXST:filing:2026-08-05:a14bc14856Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> RxSight, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/rxst/filings/us:RXST:filing:2026-08-05:74d4739a4eWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> RxSight, Inc.: Schedule 13G/A filed by Millennium Management LLC, 7.3% of the classhttps://greeksoup.ai/stocks/us/rxst/holders/us:RXST:schedule-13:2026-08-04:0d7518d589Tue, 04 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]>